151 related articles for article (PubMed ID: 15501994)
1. Impact of the cyclooxygenase system on doxorubicin-induced functional multidrug resistance 1 overexpression and doxorubicin sensitivity in acute myeloid leukemic HL-60 cells.
Puhlmann U; Ziemann C; Ruedell G; Vorwerk H; Schaefer D; Langebrake C; Schuermann P; Creutzig U; Reinhardt D
J Pharmacol Exp Ther; 2005 Jan; 312(1):346-54. PubMed ID: 15501994
[TBL] [Abstract][Full Text] [Related]
2. The cyclooxygenase system participates in functional mdr1b overexpression in primary rat hepatocyte cultures.
Ziemann C; Schäfer D; Rüdell G; Kahl GF; Hirsch-Ernst KI
Hepatology; 2002 Mar; 35(3):579-88. PubMed ID: 11870370
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism.
Zatelli MC; Luchin A; Piccin D; Tagliati F; Bottoni A; Vignali C; Bondanelli M; degli Uberti EC
J Clin Endocrinol Metab; 2005 Oct; 90(10):5754-60. PubMed ID: 16091477
[TBL] [Abstract][Full Text] [Related]
4. Lack of correlation between expression and function of P-glycoprotein in acute myeloid leukemia cell lines.
Bailly JD; Muller C; Jaffrézou JP; Demur C; Gassar G; Bordier C; Laurent G
Leukemia; 1995 May; 9(5):799-807. PubMed ID: 7769842
[TBL] [Abstract][Full Text] [Related]
5. Preferential inhibition of cyclooxygenase-2 by meloxicam in human rheumatoid synoviocytes.
Tsubouchi Y; Sano H; Yamada R; Hashiramoto A; Kohno M; Kusaka Y; Kondo M
Eur J Pharmacol; 2000 May; 395(3):255-63. PubMed ID: 10812057
[TBL] [Abstract][Full Text] [Related]
6. A new apoptosis inhibitor, CIAPIN1 (cytokine-induced apoptosis inhibitor 1), mediates multidrug resistance in leukemia cells by regulating MDR-1, Bcl-2, and Bax.
Li X; Hong L; Zhao Y; Jin H; Fan R; Du R; Xia L; Luo G; Fan D
Biochem Cell Biol; 2007 Dec; 85(6):741-50. PubMed ID: 18059532
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-2, P-glycoprotein-170 and drug resistance; is chemoprevention against multidrug resistance possible?
Ratnasinghe D; Daschner PJ; Anver MR; Kasprzak BH; Taylor PR; Yeh GC; Tangrea JA
Anticancer Res; 2001; 21(3C):2141-7. PubMed ID: 11501838
[TBL] [Abstract][Full Text] [Related]
8. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers.
Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Pajdo R; Drozdowicz D; Ptak A; Hahn EG
Microsc Res Tech; 2001 Jun; 53(5):343-53. PubMed ID: 11376495
[TBL] [Abstract][Full Text] [Related]
9. Preventing chemoresistance of human breast cancer cell line, MCF-7 with celecoxib.
Chen C; Shen HL; Yang J; Chen QY; Xu WL
J Cancer Res Clin Oncol; 2011 Jan; 137(1):9-17. PubMed ID: 20229271
[TBL] [Abstract][Full Text] [Related]
10. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
[TBL] [Abstract][Full Text] [Related]
11. Cell-specific modulation of drug resistance in acute myeloid leukemic blasts by diphtheria fusion toxin, DT388-GMCSF.
Frankel AE; Hall PD; McLain C; Safa AR; Tagge EP; Kreitman RJ
Bioconjug Chem; 1998; 9(4):490-6. PubMed ID: 9667951
[TBL] [Abstract][Full Text] [Related]
12. MPT0B169, a novel tubulin inhibitor, induces apoptosis in taxol-resistant acute myeloid leukemia cells through mitochondrial dysfunction and Mcl-1 downregulation.
Wang CC; Liu HE; Lee YL; Huang YW; Chen YJ; Liou JP; Huang HM
Tumour Biol; 2016 May; 37(5):6065-72. PubMed ID: 26608370
[TBL] [Abstract][Full Text] [Related]
13. Meloxicam inhibits osteosarcoma growth, invasiveness and metastasis by COX-2-dependent and independent routes.
Naruse T; Nishida Y; Hosono K; Ishiguro N
Carcinogenesis; 2006 Mar; 27(3):584-92. PubMed ID: 16219634
[TBL] [Abstract][Full Text] [Related]
14. The glutathione S-transferase inhibitor 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol overcomes the MDR1-P-glycoprotein and MRP1-mediated multidrug resistance in acute myeloid leukemia cells.
Ascione A; Cianfriglia M; Dupuis ML; Mallano A; Sau A; Pellizzari Tregno F; Pezzola S; Caccuri AM
Cancer Chemother Pharmacol; 2009 Jul; 64(2):419-24. PubMed ID: 19288261
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of catalase gene expression in the doxorubicin-resistant AML subline AML-2/DX100.
Kim HS; Lee TB; Choi CH
Biochem Biophys Res Commun; 2001 Feb; 281(1):109-14. PubMed ID: 11178967
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase-2: potential role in regulation of drug efflux and multidrug resistance phenotype.
Sorokin A
Curr Pharm Des; 2004; 10(6):647-57. PubMed ID: 14965327
[TBL] [Abstract][Full Text] [Related]
17. Effects of nonsteroidal anti-inflammatory drugs on the expression and function of P-glycoprotein/MDR1 in Caco-2 cells.
Takara K; Hayashi R; Kokufu M; Yamamoto K; Kitada N; Ohnishi N; Yokoyama T
Drug Chem Toxicol; 2009; 32(4):332-7. PubMed ID: 19793025
[TBL] [Abstract][Full Text] [Related]
18. [Effect of quercetin on doxorubicin-induced expression of MDR1 gene in HL-60 cells].
He HL; Ji LJ; Li QZ; Zhang R; Huang JM; Li G
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Feb; 23(1):70-6. PubMed ID: 25687049
[TBL] [Abstract][Full Text] [Related]
19. Multidrug resistance inhibition by antisense oligonucleotide against MDR1/mRNA in P-glycoprotein expressing leukemic cells.
Nadali F; Pourfathollah AA; Alimoghaddam K; Nikougoftar M; Rostami S; Dizaji A; Azizi E; Zomorodipour A; Ghavamzadeh A
Hematology; 2007 Oct; 12(5):393-401. PubMed ID: 17852455
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous suppression of multidrug resistance and antiapoptotic cellular defense induces apoptosis in chemoresistant human acute myeloid leukemia cells.
Wang X; Wang C; Qin YW; Yan SK; Gao YR
Leuk Res; 2007 Jul; 31(7):989-94. PubMed ID: 17067671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]